SIR and 95% CI in patients with pSS in Taiwan by cancer sites
| Cancer sites (ICD-9 code) | Observed | Expected | SIR | 95% CI |
|---|---|---|---|---|
| Women | ||||
| Mouth (140–145) | 3 | 2.1 | 1.42 | 0.29 to 4.16 |
| Nasopharynx (147) | 3 | 1.8 | 1.63 | 0.34 to 4.77 |
| Stomach (151) | 10 | 6.4 | 1.56 | 0.75 to 2.86 |
| Colon (153) | 3 | 13.5 | 0.22 | 0.05 to 0.65 |
| Rectum (154) | 5 | 8.2 | 0.61 | 0.20 to 1.42 |
| Liver (155) | 18 | 14.0 | 1.28 | 0.76 to 2.03 |
| Pancreas (157) | 3 | 2.6 | 1.13 | 0.23 to 3.31 |
| Lung (162) | 20 | 14.3 | 1.40 | 0.85 to 2.16 |
| Skin, excluding melanoma (173) | 4 | 2.6 | 1.56 | 0.42 to 3.99 |
| Breast, women (174) | 37 | 37.4 | 0.99 | 0.70 to 1.36 |
| Cervix uteri (180) | 7 | 10.8 | 0.65 | 0.26 to 1.34 |
| Ovary (183.0) | 6 | 4.1 | 1.46 | 0.54 to 3.19 |
| Bladder (188) | 6 | 3.4 | 1.77 | 0.65 to 3.84 |
| Kidney (189) | 5 | 4.2 | 1.18 | 0.38 to 2.76 |
| Thyroid gland (193) | 14 | 5.5 | 2.56 | 1.40 to 4.30 |
| NHL (200, 202) | 23 | 3.2 | 7.08 | 4.25 to 10.3 |
| Multiple myeloma (203) | 5 | 0.8 | 6.09 | 1.98 to 14.2 |
| Men | ||||
| Liver (155) | 5 | 7.3 | 0.69 | 0.22 to 1.61 |
| Lung (162) | 9 | 7.3 | 1.23 | 0.56 to 2.33 |
| Prostate (185) | 7 | 5.0 | 1.41 | 0.57 to 2.91 |
| NHL (200, 202) | 3 | 1.0 | 3.10 | 0.64 to 9.05 |
ICD-9, International Classification of Diseases, Ninth Revision; NHL, non-Hodgkin's lymphoma.